July 24, 2016
Recommended Topic Related To:


"The U.S. Food and Drug Administration today approved a new use for Simponi (golimumab) injection to treat adults with moderate to severe ulcerative colitis.

Simponi works by blocking tumor necrosis factor (TNF), which plays an important"...




  • Instruct patients not to take LIALDA if they have hypersensitivity to salicylates (e.g., aspirin) or other mesalamines.
  • Inform patients to let their physicians know all medications they are taking and if they:
    • are allergic to sulfasalazine, salicylates or mesalamine;
    • are taking non-steroidal anti-inflammatory drugs (NSAIDs) or other nephrotoxic agents;
    • are taking azathioprine, or 6-mercaptopurine;
    • experience cramping, abdominal pain, bloody diarrhea, fever, headache or rash;
    • have a history of myocarditis or pericarditis;
    • have kidney or liver disease;
    • have a history of stomach blockage;
    • are pregnant, intend to become pregnant or are breast-feeding.
  • Patients should be instructed to swallow LIALDA delayed-release tablets whole, taking care not to break the outer coating.

Last reviewed on RxList: 10/31/2014
This monograph has been modified to include the generic and brand name in many instances.

Report Problems to the Food and Drug Administration


You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

Women's Health

Find out what women really need.